These results indicated that p62 functions as a bridge for the recruitment of Caspase 8 on the autophagosome membrane in ovarian cancer cells treated with cisplatin and this recruitment and activation of Caspase 8 was inhibited by mutation of key domains in p62. This evidence concerns the gene SQSTM1 and ovarian carcinoma.